BOT 1.43% 34.5¢ botanix pharmaceuticals ltd

Ann: FDA Letter Requires Patient Instruction Update, page-59

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 324 Posts.
    lightbulb Created with Sketch. 91
    Webinar is good. It’s a delay. 3-6m

    seems little to no concern.

    no efficacy or safety issues.

    market could get marginally larger in this time.

    the requirement to resubmit is not complex.

    they have cash. No cap raise it seems. Fully funded to reach revised approval date.

    FDA takes 6m. But the time to complete resubmission is circa. 2 months.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.